Papapetropoulos Spyros 4
4 · Lipocine Inc. · Filed Apr 12, 2022
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Papapetropoulos Spyros
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-11$1.16/sh+10,000$11,600→ 10,000 totalExercise: $1.16From: 2023-04-11Exp: 2032-04-11→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of April 11, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.